TY - JOUR
T1 - Current management of immune thrombocytopenia
AU - Neunert, Cindy E.
PY - 2013
Y1 - 2013
N2 - Immune thrombocytopenia (ITP) is an autoimmune-mediated condition that results from antibody-mediated destruction of platelets and impaired megakaryocyte platelet production. ITP patients exhibit severe thrombocytopenia and are at risk for significant hemorrhage. Few randomized trials exist to guide management of patients with ITP. Ultimately, each patient requires an individualized treatment plan that takes into consideration the platelet count, bleeding symptoms, health-related quality of life, and medication side effects. This article provides an up-to-date review of management strategies drawing on links between the expanding amounts of clinical trial data and associated biology studies to enhance understanding of the disease heterogeneity with regard to the complex pathogenesis and response to treatment.
AB - Immune thrombocytopenia (ITP) is an autoimmune-mediated condition that results from antibody-mediated destruction of platelets and impaired megakaryocyte platelet production. ITP patients exhibit severe thrombocytopenia and are at risk for significant hemorrhage. Few randomized trials exist to guide management of patients with ITP. Ultimately, each patient requires an individualized treatment plan that takes into consideration the platelet count, bleeding symptoms, health-related quality of life, and medication side effects. This article provides an up-to-date review of management strategies drawing on links between the expanding amounts of clinical trial data and associated biology studies to enhance understanding of the disease heterogeneity with regard to the complex pathogenesis and response to treatment.
UR - http://www.scopus.com/inward/record.url?scp=84898846064&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84898846064&partnerID=8YFLogxK
U2 - 10.1182/asheducation-2013.1.276
DO - 10.1182/asheducation-2013.1.276
M3 - Review article
C2 - 24319191
AN - SCOPUS:84898846064
SN - 1520-4391
VL - 2013
SP - 276
EP - 282
JO - Hematology / the Education Program of the American Society of Hematology. American Society of Hematology. Education Program
JF - Hematology / the Education Program of the American Society of Hematology. American Society of Hematology. Education Program
ER -